Pfizer
PFE
PFE
2,768 hedge funds and large institutions have $92B invested in Pfizer in 2025 Q3 according to their latest regulatory filings, with 200 funds opening new positions, 1,099 increasing their positions, 1,202 reducing their positions, and 150 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 1,099 | Existing positions reduced: 1,202
1.94% less ownership
Funds ownership: 65.5% → 63.56% (-1.9%)
15% less call options, than puts
Call options by funds: $2.58B | Put options by funds: $3.02B
Holders
2,768
Holding in Top 10
34
Calls
$2.58B
Puts
$3.02B
Top Buyers
| 1 | +$248M | |
| 2 | +$207M | |
| 3 | +$166M | |
| 4 |
Neuberger Berman Group
New York
|
+$154M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$152M |
Top Sellers
| 1 | -$456M | |
| 2 | -$421M | |
| 3 | -$312M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$291M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$247M |